Pedro Méndez

3.4k total citations
39 papers, 1.8k citations indexed

About

Pedro Méndez is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pedro Méndez has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pedro Méndez's work include Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (11 papers) and RNA modifications and cancer (10 papers). Pedro Méndez is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (11 papers) and RNA modifications and cancer (10 papers). Pedro Méndez collaborates with scholars based in Spain, United States and Poland. Pedro Méndez's co-authors include Miquel Tarón, José Javier Sánchez, Rafael Rosell, Cristina Queralt, Rafael Rosell, Enriqueta Felip, John Souglakos, J Maestre, Joaquim Majó Fernández and Fabiana Letizia Cecere and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Pedro Méndez

36 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Méndez Spain 17 991 762 683 550 295 39 1.8k
Michael Pins United States 25 1.1k 1.1× 795 1.0× 891 1.3× 418 0.8× 428 1.5× 53 2.0k
K. D. Danenberg United States 15 1.1k 1.1× 555 0.7× 825 1.2× 422 0.8× 167 0.6× 41 1.8k
Vincent Haddad United Kingdom 16 907 0.9× 1.3k 1.8× 1.5k 2.2× 485 0.9× 246 0.8× 36 2.9k
Tae-You Kim South Korea 24 678 0.7× 420 0.6× 689 1.0× 277 0.5× 168 0.6× 48 1.5k
Hiroaki Asano Japan 28 1.3k 1.3× 1.4k 1.8× 1.1k 1.6× 842 1.5× 257 0.9× 82 2.8k
Luc Cabel France 24 487 0.5× 599 0.8× 1.2k 1.7× 924 1.7× 182 0.6× 81 1.9k
Karin Bowen United States 15 809 0.8× 942 1.2× 1.3k 1.9× 359 0.7× 222 0.8× 30 2.8k
Carmen Belli Italy 20 550 0.6× 517 0.7× 1.0k 1.5× 401 0.7× 282 1.0× 60 1.7k
Marlies H.G. Langenberg Netherlands 15 604 0.6× 417 0.5× 749 1.1× 367 0.7× 79 0.3× 34 1.3k

Countries citing papers authored by Pedro Méndez

Since Specialization
Citations

This map shows the geographic impact of Pedro Méndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Méndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Méndez more than expected).

Fields of papers citing papers by Pedro Méndez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Méndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Méndez. The network helps show where Pedro Méndez may publish in the future.

Co-authorship network of co-authors of Pedro Méndez

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Méndez. A scholar is included among the top collaborators of Pedro Méndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Méndez. Pedro Méndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, Marco A., et al.. (2021). High-Dimensional Immunophenotyping with 37-Color Panel Using Full-Spectrum Cytometry. Methods in molecular biology. 2386. 43–60. 7 indexed citations
2.
Méndez, Pedro, Li Tai Fang, David M. Jablons, & Il-Jin Kim. (2017). Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues. Scientific Reports. 7(1). 4055–4055. 7 indexed citations
3.
Méndez, Pedro, Sharon Lee, Junhee Yoon, et al.. (2016). Development of a robust DNA quality and quantity assessment qPCR assay for targeted next-generation sequencing library preparation. International Journal of Oncology. 49(4). 1755–1765. 12 indexed citations
4.
Morales-Espinosa, Daniela, Miguel Ángel Molina‐Vila, Ana Giménez‐Capitán, et al.. (2016). CHK1 inhibition as a therapeutic approach in KRAS mutated and squamous cell carcinoma NSCLC patients.. Journal of Clinical Oncology. 34(15_suppl). 11581–11581. 1 indexed citations
5.
Méndez, Pedro, Sharon Lee, Junhee Yoon, et al.. (2016). Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories. International Journal of Oncology. 49(1). 235–242. 7 indexed citations
6.
Bover, Isabel, Christian Rolfo, Eloísa Jantus‐Lewintre, et al.. (2011). Fifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology Workshop. Lung Cancer. 74(3). 535–543.
7.
Méndez, Pedro, et al.. (2011). A modified host-cell reactivation assay to quantify DNA repair capacity in cryopreserved peripheral lymphocytes. DNA repair. 10(6). 603–610. 16 indexed citations
8.
Carcereny, Enric, José Luis Ramírez, María Sanchez-Ronco, et al.. (2009). Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients. Lung Cancer. 68(3). 491–497. 9 indexed citations
9.
Skrzypski, Marcin, Ewa Jassem, Miquel Tarón, et al.. (2008). Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung. Clinical Cancer Research. 14(15). 4794–4799. 84 indexed citations
10.
Souglakos, John, Ioannis Boukovinas, Miquel Tarón, et al.. (2008). Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine. British Journal of Cancer. 98(10). 1710–1715. 90 indexed citations
11.
Rosell, R., Nerea Martı́nez, Imane Chaib, et al.. (2007). Expression of XPG mRNA and protein as potential biomarker of response to trabectedin in sarcoma patients. Molecular Cancer Therapeutics. 6. 2 indexed citations
12.
Rosell, Rafael, Pedro Méndez, Dolores Isla, & Miquel Tarón. (2007). Platinum Resistance Related to a Functional NER Pathway. Journal of Thoracic Oncology. 2(12). 1063–1066. 29 indexed citations
13.
Peñas, R. de las, M. Sánchez-Ronco, Vicente Alberola, et al.. (2006). Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Annals of Oncology. 17(4). 668–675. 145 indexed citations
14.
Rosell, Rafael, Teresa Morán, Pedro Méndez, et al.. (2006). The place of targeted therapies in the management of non-small cell bronchial carcinoma. Revue des Maladies Respiratoires. 23(5). 131–136. 6 indexed citations
15.
16.
Rosell, Rafael, Yukito Ichinose, Miquel Tarón, et al.. (2005). Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer. Lung Cancer. 50(1). 25–33. 54 indexed citations
17.
Felip, Enriqueta, Rafael Rosell, Miquel Tarón, et al.. (2004). ERCC1, RRM1 and XPD mRNA expression as a predictive marker of outcome in non-small-cell lung cancer (NSCLC) patients after platinum/gemcitabine induction chemotherapy followed by surgery. Journal of Clinical Oncology. 22(14_suppl). 7142–7142. 1 indexed citations
18.
Rosell, Rafael, Miquel Tarón, Aurelio Ariza, et al.. (2004). Molecular predictors of response to chemotherapy in lung cancer. Seminars in Oncology. 31(1 Suppl 1). 20–27. 72 indexed citations
19.
Tarón, Miquel, Rafael Rosell, John Souglakos, et al.. (2004). BRCA1 and HIF-1α mRNA expression and chemoresistance in non-small-cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7148–7148. 1 indexed citations
20.
Méndez, Pedro, Kia Saeian, K. Rajender Reddy, et al.. (2001). Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations. The American Journal of Gastroenterology. 96(8). 2489–2493. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Pins Breakdown of academic impact, for papers by K. D. Danenberg Breakdown of academic impact, for papers by Vincent Haddad Breakdown of academic impact, for papers by Tae-You Kim Breakdown of academic impact, for papers by Hiroaki Asano Breakdown of academic impact, for papers by Luc Cabel Breakdown of academic impact, for papers by Karin Bowen Breakdown of academic impact, for papers by Carmen Belli Breakdown of academic impact, for papers by Marlies H.G. Langenberg
Rankless by CCL
2026